TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
PGEN

Precigen Inc

Healthcare · Biotechnology

7.70$ -1.0% vs. previous close Closing price · As of: Sep 21, 2026

Statements

Cash Flow

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Cash Flow PGEN
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
-256.9%
+70.4% +38.5% +26.7% +6.3% -47.1% +0.0% -21.4% -21.8% -38.1% -32.1% -29.3%
+349.6% -47.2% -0.5% -10.8% -60.9% +0.0% -24.3% -26.6% -3.1% -4.2% +14.7%
+32.0% +24.4% +15.2% +50.1% +34.9% -68.0% -75.6% -7.5%
+373.1% -130.2% -73.5% +46.5%
+100.1% +148.1% +47.5% -10.9% -81.9% +0.0% -3.7% -32.1% -68.8% +458.9% -76.8%
+902.0% -89.1% -244.9% +0.0% -368.3% -101.4% +571.0% -92.6%
-81.6%
-100.2% +0.0% -86.6% +11,119.5% -98.3% -99.8% -100.0%
+43.3% -87.6% +97.7% -99.4% -298.7% -80.7% +33,224.7% -72.2% -100.0%
+1,288.3% -96.4% -64.5% +7,131.4% -89.4% +0.0% +270.5% -228.1% +273.7% -18.6%
-167.6% +529.3% -146.7% -875.7% -96.7%
-482.2%

Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?